BRIEF-M Pharmaceutical Mathew Lehman resigns as President and CEO

Tue Mar 15, 2016 7:41am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 15 (Reuters) - M Pharmaceutical Inc

* Mathew Lehman has resigned from board of directors and from his position as President and CEO

* Company is undertaking a search for a new CEO

* Previously announced letter of intent to acquire reformulated Orlistat from Chelatexx, LLC allowed to lapse by parties Source text for Eikon: Further company coverage: